GLP-3 | Retatrutide

100.00

 

 

PRODUCT OVERVIEW

Parameter Details
Product Name Retatrutide (LY3437943)
Also Known As GLP-3, Triple G agonist, Triple agonist peptide
Sequence Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-
{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-
Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Molecular Formula C221H342N46O68
Molecular Weight 4731.33 g/mol
CAS Number 2381089-83-2
PubChem CID 485663353
Purity ≥98% (HPLC/MS tested)
Form Lyophilized white to off-white powder
Source Synthetic
Length (aa) 39

 

Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Buy GLP-3 | Retatrutide Peptides EU

GLP-3, known scientifically as Retatrutide (LY3437943), represents a significant advancement in metabolic research peptides. This synthetic 39-amino acid peptide functions as a balanced triple agonist at the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Buy GLP-3 | Retatrutide Research Peptide EU

For researchers conducting studies on metabolic pathways, energy expenditure, and body composition regulation, retatrutide offers a unique mechanism of action distinct from single or dual agonist compounds. Phase 2 clinical data published in The New England Journal of Medicine demonstrated up to 24.2% mean weight reduction at 48 weeks in clinical trial participants. Buy GLP-3 | Retatrutide Research Peptide EU

All products are strictly for research use only and comply with EU laboratory standards. Visit our homepage at euresearchpeptides.com to explore our full range of buy peptides EU products. Buy GLP-3 | Retatrutide Research Peptide EU

Receptor Binding Profile

Retatrutide demonstrates potent activity across three distinct receptor targets relevant to metabolic research:

Receptor EC50 Value
GIPR (Glucose-dependent Insulinotropic Polypeptide Receptor) 0.0643 nM
GLP-1R (Glucagon-like Peptide-1 Receptor) 0.775 nM
GCGR (Glucagon Receptor) 5.79 nM

This balanced triple agonist profile distinguishes retatrutide from single agonists (semaglutide) and dual agonists (tirzepatide) for comparative research applications.


Purity Specifications & Quality Assurance

HPLC/MS Data

Our retatrutide research peptide undergoes rigorous analytical testing:

  • HPLC purity: ≥98% as verified by independent testing

  • Individual impurities: Not more than 1.0%

  • Total impurities: Not more than 2.0%

  • Peptide content: ≥80%

Endotoxin Testing

  • Bacterial endotoxin: <10 EU/mg

  • Compliant with research-grade standards

Residual Solvents Analysis

Solvent Limit
Methanol ≤0.3%
Isopropanol ≤0.5%
Acetonitrile ≤0.041%
Methylene Chloride ≤0.06%
DMF ≤0.088%
Triethylamine ≤0.032%
TBME ≤0.5%

Additional Quality Parameters

  • Appearance: White to off-white powder or loose lump

  • Water content: Not more than 10.0%

  • pH (in solution): 6.0 – 9.0

  • Acetic Acid: Not more than 0.5%

  • Trifluoroacetate Ion: Not more than 0.1%

  • Sodium Ion: Not more than 3.0%

Each batch includes a Certificate of Analysis (COA) with HPLC chromatogram and mass spectrometry data. For researchers sourcing high purity peptides Germany, our quality standards meet rigorous laboratory requirements.


Solubility Profile

Recommended Solvents

Solvent Solubility Notes
Water (H2O) 20 mg/mL Ultrasonic assistance required; adjust pH to 9 with aqueous NH3
DMSO 50 mg/mL Ultrasonic assistance required; use newly opened DMSO

Reconstitution Guidelines for Research Peptides

For proper reconstitution of your retatrutide research peptide:

  1. Allow lyophilized peptide vial to reach room temperature (15-25°C) before opening

  2. Prepare sterile bacteriostatic water or sterile water for injection

  3. Calculate required volume based on desired concentration

  4. Inject diluent slowly down the inner glass wall of the vial

  5. Gently swirl until complete dissolution – do not shake vigorously

  6. Avoid repeated freeze-thaw cycles of reconstituted solutions

Concentration Reference

Example: Reconstituting 10mg retatrutide with 2mL diluent yields 5mg/mL concentration.

For researchers conducting laboratory peptides Netherlands studies, proper reconstitution is critical for reproducible research outcomes.


Stability Data & Storage Recommendations

Lyophilized Powder Storage

Storage Condition Stability Period
-80°C 2 years
-20°C 1 year
2-8°C (refrigerated) 3-6 months
Room temperature (15-25°C) Not recommended

Reconstituted Solution Storage

Storage Condition Stability Period
-80°C (aliquoted, sealed) 6 months
-20°C (aliquoted, sealed) 1 month
2-8°C (refrigerated) 14-28 days

Important Stability Notes

  • Keep sealed, away from moisture and light

  • Store under nitrogen when possible

  • Once prepared, store stock solutions in tightly sealed vials

  • Use within 1 month of reconstitution

  • Do not subject to repeated freeze-thaw cycles

For peptide synthesis Europe researchers, proper storage ensures compound integrity throughout the study period.


Known Research Applications

Metabolic Research

Retatrutide is being studied for its effects on:

  • Body weight regulation and fat mass reduction

  • Energy expenditure modulation

  • Appetite control and satiety signaling

  • Resting metabolic rate enhancement

Cardiometabolic Studies

The TRIUMPH Phase 3 clinical development program (with over 5800 participants) is evaluating retatrutide for:

  • Obesity treatment (TRIUMPH-1, -2, -3)

  • Obstructive sleep apnea (OSA) nested within weight management trials

  • Knee osteoarthritis (OA) pain reduction – up to 75.8% pain score improvement in TRIUMPH-4

Metabolic Comorbidity Research

Published research indicates applications for:

  • Non-alcoholic steatohepatitis (NASH) studies

  • Type 2 diabetes metabolic parameters

  • Lipid metabolism profiling

  • Amino acid and metabolite regulation

Comparative Pharmacology

Researchers studying peptide supplier Spain products may use retatrutide to compare:

  • Triple agonist vs. dual agonist (tirzepatide) mechanisms

  • Triple agonist vs. single agonist (semaglutide) activity

  • GIPR-enhanced vs. GLP-1R selective activation

Citation References

  • Phase 2 clinical results published in The New England Journal of Medicine

  • TRIUMPH trial design published in Diabetes, Obesity and Metabolism, Volume 28, Issue 1, pages 83-93 (2026)

  • Triple-agonist review in Clinical Pharmacology in Drug Development (2026)


Proper Handling Protocols

Required Safety Equipment

  • Powder-free nitrile gloves

  • Safety goggles

  • Laboratory coat

  • Laminar flow hood recommended

Handling Procedures

  1. Work in a clean, designated laboratory area

  2. Use sterile techniques for all manipulations

  3. Avoid skin contact with powder or reconstituted solutions

  4. Weigh or measure only under appropriate containment

  5. Decontaminate work surfaces before and after use

Disposal Guidelines

  • Dispose of unused peptide as chemical waste per local regulations

  • Decontaminate all surfaces and tools with appropriate disinfectant

  • Follow institutional guidelines for research chemical disposal

For research chemicals EU compliant handling, always adhere to local laboratory safety regulations.


Safety Considerations

Hazard Identification

  • For laboratory research use only

  • Not for human consumption or clinical use

  • Not approved by FDA or EMA for therapeutic applications

  • Avoid inhalation, ingestion, or skin contact

First Aid Measures

Exposure Action
Skin contact Wash immediately with soap and water for 15 minutes
Eye contact Rinse thoroughly with water for 15 minutes; seek medical attention
Inhalation Move to fresh air; seek medical attention if respiratory irritation occurs
Ingestion Do not induce vomiting; seek immediate medical attention

Regulatory Status

Retatrutide is currently an investigational compound in Phase 3 clinical trials. It is not FDA-approved and is not available in pharmacies. Any products purporting to be retatrutide outside of clinical trials are for research use only.

Researchers purchasing retatrutide for research purposes must be affiliated with a recognized research institution.


Why Choose Euresearchpeptides.com

As a premium EU-based online retailer, we provide:

  • EU Warehousing – Fast shipping across Germany, France, Netherlands, Spain, and all EU member states

  • Verified Purity – Every batch includes Certificate of Analysis with HPLC/MS data

  • Third-Party Testing – Independent verification by certified laboratories

  • EU Compliance – Full adherence to EU research chemical regulations

  • Discreet Packaging – Professional laboratory packaging

  • Dedicated Support – Research protocol assistance available

Shop with confidence for all your GLP-1 research peptides EU needs.


 FAQ Section

Q1: Where can I buy high purity retatrutide for research in Europe?

You can purchase retatrutide research peptide directly from euresearchpeptides.com, a trusted supplier serving Germany, France, Netherlands, Spain, and all EU countries. Each batch includes HPLC/MS verification. Order now for EU delivery.

Q2: What is the difference between retatrutide, tirzepatide, and semaglutide?

Retatrutide is a triple agonist activating GLP-1, GIP, and glucagon receptors, whereas tirzepatide is a dual agonist (GLP-1/GIP) and semaglutide is a single GLP-1 agonist. This triple mechanism makes retatrutide unique for comparative metabolic research studies. Shop retatrutide for research.

Q3: What purity level does your retatrutide research peptide have?

Our retatrutide is tested at ≥98% purity by HPLC with complete Certificate of Analysis provided. Third-party verification ensures quality standards for serious research applications. Buy high purity peptides Germany from our EU warehouse.

Q4: How should I store lyophilized retatrutide?

Store lyophilized retatrutide at -20°C or -80°C for long-term stability up to 2 years. Keep sealed, away from moisture and light. For reconstituted solutions, refrigerate at 2-8°C and use within 30 days. Purchase retatrutide with storage protocols included.

Q5: What solvents are recommended for retatrutide reconstitution?

Retatrutide is soluble in water (20 mg/mL with pH adjustment to 9 using NH3) and DMSO (50 mg/mL with ultrasonication). For research peptides France applications, sterile bacteriostatic water is the standard reconstitution diluent. Order reconstitution supplies with your peptide.

Q6: Is retatrutide FDA-approved for research use?

Retatrutide is not FDA-approved and is available exclusively for laboratory research purposes. It is an investigational compound in Phase 3 clinical trials. Researchers must be affiliated with recognized institutions. Buy research peptides EU compliant from our store.

Q7: What receptor targets does retatrutide activate?

Retatrutide activates three receptors: GIPR (EC50 0.0643 nM), GLP-1R (EC50 0.775 nM), and GCGR (EC50 5.79 nM). This balanced triple agonist profile enables comprehensive metabolic pathway studies. Purchase triple agonist peptide for your research.

Q8: What clinical research has been published on retatrutide?

Phase 2 results in The New England Journal of Medicine showed up to 24.2% weight reduction. Phase 3 TRIUMPH trials are ongoing with over 5800 participants studying obesity, sleep apnea, and osteoarthritis. Laboratory peptides Netherlands researchers can access full citation data.

Q9: How quickly will my retatrutide order arrive in Europe?

EU orders typically arrive within 3-7 business days from our European warehouse. Express shipping available at checkout. All orders include Certificate of Analysis and proper handling documentation. Shop peptide supplier Spain trusted products today.

Q10: Do you provide Certificate of Analysis with each batch?

Yes, every retatrutide research peptide includes a comprehensive COA with HPLC purity data, mass spectrometry verification, and endotoxin testing results. Batch-specific documentation is available upon request. Buy peptides EU with verified quality standards.

Q11: Can retatrutide be used for nasal spray research administration?

Retatrutide is typically studied via subcutaneous injection in clinical research. For alternative administration route studies, researchers should validate stability and absorption parameters independently. Contact our team for peptide synthesis Europe consultation.

Q12: What is the molecular weight and formula of retatrutide?

Retatrutide has molecular formula C221H342N46O68 and molecular weight 4731.33 g/mol. It is a 39-amino acid synthetic peptide with non-coded residues including Aib and alpha-Me-Leu. Order research grade retatrutide for metabolic studies.

Reviews

There are no reviews yet.

Be the first to review “GLP-3 | Retatrutide”

Your email address will not be published. Required fields are marked *